USA Intrauterine Contraceptive Devices (IUD) Market: By Method (Hormonal Intrauterine Devices and Copper Intrauterine Devices), By End-User (Hospitals, Gynecology Clinics, Community Health Care Centers, and Others), and Geography

USA Intrauterine Contraceptive Devices (IUD) Market size was valued at USD 1,072.3 million in 2023 and is expected to grow at a CAGR of 4.0% from 2024 to 2030. USA intrauterine Contraceptive Devices (IUD). According to the World Health Organization (WHO), an intrauterine device (IUD) is a long-term contraception method. IUDs are small devices that are placed inside the uterus (womb) to prevent pregnancy. IUDs are more potential and reliable, lasting for more than 5 years. The vital factors for the growth of the intrauterine contraceptive devices (IUD) market include technology advancements resulting in effective contraception and a subordinate number of side effects, the rising rate of unintended pregnancies, and favorable government initiatives and private firms for the prohibition of unwanted abortions and pregnancies. An unintended pregnancy is an unsolicited pregnancy. Not utilizing contraceptives or inappropriate use of contraceptive methods can result in unintended pregnancies.

The probability of unintended is mores in juveniles younger than 18 years and, later on, women in the age group of 21 to 25 years. these unintended pregnancies are directly contributing to the increased demand for intrauterine contraceptive devices. Furthermore, the number of unsolicited pregnancies is rising, and this has become of serious concern. For instance, according to the World Health Organization (WHO), unintended pregnancies have been a crucial public health issue. about 24 million unsafe abortions were evaluated to take place each year, which resulted in the death of an evaluated 52,000 women, as per the International Federation of Medical Students' Associations 2018 review. However, the high cost of treatment, the stringent regulatory framework for product approval, and high R&D expenditure remain substantial barriers that hamper the growth of the USA intrauterine Contraceptive Devices (IUD) market However, the key opportunities associated with these drugs are enhanced affordability and patient access to these critical treatments, geographical expansion by the market players, and government incentives for R&D activities create opportunity for the players in the USA intrauterine Contraceptive Devices (IUD) market.

USA Intrauterine Contraceptive Devices (IUD) Market Key Developments:

In June 2021, Sebela Pharmaceuticals Inc., in association with PRA Health Sciences is regulating a phase III clinical trial to evaluate LevoCept, a long-acting reversible intrauterine system for contraceptive tolerability, safety, and efficacy.